Ortivus AB ser. A (ORTI-A) - Total Assets
Based on the latest financial reports, Ortivus AB ser. A (ORTI-A) holds total assets worth Skr68.95 Million SEK (≈ $7.42 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Ortivus AB ser. A cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Ortivus AB ser. A - Total Assets Trend (2003–2025)
This chart illustrates how Ortivus AB ser. A's total assets have evolved over time, based on quarterly financial data. Check Ortivus AB ser. A (ORTI-A) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Ortivus AB ser. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Ortivus AB ser. A's total assets of Skr68.95 Million consist of 42.0% current assets and 58.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr8.89 Million | 12.5% |
| Accounts Receivable | Skr10.87 Million | 15.3% |
| Inventory | Skr4.66 Million | 6.6% |
| Property, Plant & Equipment | Skr2.51 Million | 3.5% |
| Intangible Assets | Skr36.30 Million | 51.2% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2003–2025)
This chart illustrates how Ortivus AB ser. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Ortivus AB ser. A.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ortivus AB ser. A's current assets represent 42.0% of total assets in 2025, a decrease from 59.6% in 2003.
- Cash Position: Cash and equivalents constituted 12.5% of total assets in 2025, down from 36.0% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 20.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 51.2% of total assets.
Ortivus AB ser. A Competitors by Total Assets
Key competitors of Ortivus AB ser. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Tarsons Products Limited
NSE:TARSONS
|
India | Rs11.64 Billion |
|
SciVision Biotech Inc
TW:1786
|
Taiwan | NT$2.67 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
Ortivus AB ser. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 0.80 | 1.28 |
| Quick Ratio | 1.01 | 0.57 | 1.15 |
| Cash Ratio | 0.00 | 0.06 | 0.46 |
| Working Capital | Skr4.81 Million | Skr-6.55 Million | Skr11.92 Million |
Ortivus AB ser. A - Advanced Valuation Insights
This section examines the relationship between Ortivus AB ser. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.10 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 11.0% |
| Total Assets | Skr70.93 Million |
| Market Capitalization | $393.65K USD |
Valuation Analysis
Below Book Valuation: The market values Ortivus AB ser. A's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ortivus AB ser. A's assets grew by 11.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ortivus AB ser. A (2003–2025)
The table below shows the annual total assets of Ortivus AB ser. A from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr70.93 Million ≈ $7.63 Million |
+10.99% |
| 2024-12-31 | Skr63.91 Million ≈ $6.88 Million |
-12.10% |
| 2023-12-31 | Skr72.71 Million ≈ $7.82 Million |
-18.99% |
| 2022-12-31 | Skr89.75 Million ≈ $9.66 Million |
+23.86% |
| 2021-12-31 | Skr72.46 Million ≈ $7.80 Million |
+8.88% |
| 2020-12-31 | Skr66.55 Million ≈ $7.16 Million |
+90.47% |
| 2019-12-31 | Skr34.94 Million ≈ $3.76 Million |
+26.15% |
| 2018-12-31 | Skr27.70 Million ≈ $2.98 Million |
-19.81% |
| 2017-12-31 | Skr34.54 Million ≈ $3.72 Million |
-26.89% |
| 2016-12-31 | Skr47.25 Million ≈ $5.08 Million |
-28.46% |
| 2015-12-31 | Skr66.05 Million ≈ $7.11 Million |
-20.24% |
| 2014-12-31 | Skr82.80 Million ≈ $8.91 Million |
+125.13% |
| 2013-12-31 | Skr36.78 Million ≈ $3.96 Million |
-30.85% |
| 2012-12-31 | Skr53.19 Million ≈ $5.72 Million |
+4.23% |
| 2011-12-31 | Skr51.03 Million ≈ $5.49 Million |
-38.89% |
| 2010-12-31 | Skr83.51 Million ≈ $8.99 Million |
-49.12% |
| 2009-12-31 | Skr164.13 Million ≈ $17.66 Million |
-9.46% |
| 2008-12-31 | Skr181.28 Million ≈ $19.51 Million |
-28.48% |
| 2007-12-31 | Skr253.45 Million ≈ $27.27 Million |
-24.09% |
| 2006-12-31 | Skr333.90 Million ≈ $35.93 Million |
-6.28% |
| 2005-12-31 | Skr356.27 Million ≈ $38.34 Million |
+37.62% |
| 2004-12-31 | Skr258.87 Million ≈ $27.86 Million |
-1.34% |
| 2003-12-31 | Skr262.38 Million ≈ $28.24 Million |
-- |
About Ortivus AB ser. A
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more